| Date | Time | Headline | Source |
|---|---|---|---|
| 12/05/2022 | 06:32 | Spexis to present at BioEquity Europe 2022 | EQS Group |
| 27/04/2022 | 06:16 | Spexis Annual General Meeting 2022 | EQS Group |
| 01/04/2022 | 06:01 | Spexis publishes invitation to Annual General Meeting 2022 | EQS Group |
| 24/03/2022 | 06:17 | Spexis provides business update and announces financial results for the full-year 2021 | EQS Group |
| 09/03/2022 | 06:26 | Spexis to present strategy update and full-year 2021 financial results on March 24, 2022 | EQS Group |
| 03/03/2022 | 06:16 | Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization | EQS Group |
| 30/04/2021 | 07:00 | Net Asset Value(s) | RNS |
| 28/04/2021 | 12:54 | Net Asset Value(s) | RNS |
| 28/04/2021 | 07:00 | Net Asset Value(s) | RNS |
| 19/04/2021 | 07:00 | Net Asset Value(s) | RNS |